Chronic HBV Infection among women of child-bearing age (13–45 years).
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
Chronic HBV Infection among women of child-bearing age (13–45 years).
应用场景：
创建时间：
2021-05-27
相关数据集
Scenario Content Description; Evolution of Scores on New Scenarios by Scenario and Block.
Abbreviations. AIDS: acquired immune deficiency syndrome; ART: antiretroviral therapy; HIV: human immunodeficiency virus; IRIS: immune reconstitution inflammatory syndrome; PMCT: prevention of mother
Figshare2015-12-02 更新70
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique
BackgroundFew data on HIV resistance in pregnancy are available from Mozambique, one of the countries with the highest HIV toll worldwide. Understanding the patterns of HIV drug resistance in pregnant
Figshare2018-05-09 更新50
MOESM4 of A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT)
Additional file 4. 1 â Full Panel after Part 1.dta. Information on file format. STATA dataset (version 14 and 15).
DataCite Commons2020-08-26 更新40
A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Triple Antiretroviral Regimens in HIV Infected Women Initiated Between 28 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission
P1081 was a Phase IV multicenter, randomized, open-label trial comparing the virologic response, safety, and tolerability of raltegravir. The study population included Human Immunodeficiency Virus (HI
DataCite Commons2022-11-16 更新60
Maternal diagnosis categories (medical officer determination) in A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Triple Antiretroviral Regimens in HIV Infected Women Initiated Between 28 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission
Maternal diagnosis categories (medical officer determination) dataset Study Description P1081 was a Phase IV multicenter, randomized, open-label trial comparing the virologic response, safety, and tol
NIAID Data Ecosystem40
